Loading...

We've got a brand new version of Simply Wall St! Try it out

TILT Holdings

CNSX:TILT
Snowflake Description

High growth potential and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
TILT
CNSX
CA$145M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

TILT Holdings Inc., a vertically-integrated infrastructure and technology cannabis company, provides various products and services to businesses operating in the cannabis industry in the United States, Canada, and Europe. The last earnings update was 23 days ago. More info.


Add to Portfolio Compare Print
  • TILT Holdings has significant price volatility in the past 3 months.
TILT Share Price and Events
7 Day Returns
-8.7%
CNSX:TILT
-0.2%
CA Pharmaceuticals
1.2%
CA Market
1 Year Returns
-
CNSX:TILT
-45.8%
CA Pharmaceuticals
-0.4%
CA Market
TILT Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
TILT Holdings (TILT) -8.7% -44.8% -58.3% - - -
CA Pharmaceuticals -0.2% -1.8% -21.5% -45.8% 251% 334.4%
CA Market 1.2% 3.3% 0.8% -0.4% 7.4% 4.5%
1 Year Return vs Industry and Market
  • No trading data on TILT.
  • No trading data on TILT.
Price Volatility
Industry
5yr Volatility vs Market

TILT Value

 Is TILT Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of TILT Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for TILT Holdings.

CNSX:TILT Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7.8%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for CNSX:TILT
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.7
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.704 (1 + (1- 21%) (50.56%))
0.99
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.99
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (0.99 * 5.96%)
7.85%

Discounted Cash Flow Calculation for CNSX:TILT using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for TILT Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

CNSX:TILT DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.85%)
2020 153.60 Analyst x1 142.42
2021 325.91 Est @ 112.18% 280.21
2022 583.73 Est @ 79.11% 465.36
2023 910.39 Est @ 55.96% 672.98
2024 1,272.33 Est @ 39.76% 872.10
2025 1,633.85 Est @ 28.41% 1,038.42
2026 1,968.36 Est @ 20.47% 1,160.00
2027 2,261.95 Est @ 14.92% 1,236.04
2028 2,511.33 Est @ 11.03% 1,272.47
2029 2,719.82 Est @ 8.3% 1,277.84
Present value of next 10 years cash flows $8,417.00
CNSX:TILT DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $2,719.82 × (1 + 1.95%) ÷ (7.85% – 1.95%)
$46,999.34
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $46,999.34 ÷ (1 + 7.85%)10
$22,081.43
CNSX:TILT Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $8,417.00 + $22,081.43
$30,498.43
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $30,498.43 / 304.80
$100.06
CNSX:TILT Discount to Share Price
Calculation Result
Exchange Rate USD/CAD
(Reporting currency to currency of CNSX:TILT)
1.325
Value per Share
(CAD)
= Value per Share in USD x Exchange Rate (USD/CAD)
= $100.06 x 1.325
CA$132.62
Value per share (CAD) From above. CA$132.62
Current discount Discount to share price of CA$0.48
= -1 x (CA$0.48 - CA$132.62) / CA$132.62
99.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price TILT Holdings is available for.
Intrinsic value
>50%
Share price is CA$0.48 vs Future cash flow value of CA$132.62
Current Discount Checks
For TILT Holdings to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • TILT Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • TILT Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for TILT Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are TILT Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:TILT PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in USD $-2.19
CNSX:TILT Share Price ** CNSX (2019-09-19) in CAD CA$0.48
CNSX:TILT Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.36
Canada Pharmaceuticals Industry PE Ratio Median Figure of 13 Publicly-Listed Pharmaceuticals Companies 18.72x
Canada Market PE Ratio Median Figure of 540 Publicly-Listed Companies 14.11x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of TILT Holdings.

CNSX:TILT PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:TILT Share Price ÷ EPS (both in USD)

= 0.36 ÷ -2.19

-0.16x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TILT Holdings is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • TILT Holdings is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does TILT Holdings's expected growth come at a high price?
Raw Data
CNSX:TILT PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -0.16x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
153.1%per year
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.57x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for TILT Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on TILT Holdings's assets?
Raw Data
CNSX:TILT PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in USD $1.12
CNSX:TILT Share Price * CNSX (2019-09-19) in CAD CA$0.48
CNSX:TILT Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.754 $0.36
Canada Pharmaceuticals Industry PB Ratio Median Figure of 151 Publicly-Listed Pharmaceuticals Companies 2.32x
Canada Market PB Ratio Median Figure of 2,454 Publicly-Listed Companies 1.44x
CNSX:TILT PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:TILT Share Price ÷ Book Value per Share (both in USD)

= 0.36 ÷ 1.12

0.32x

* Primary Listing of TILT Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • TILT Holdings is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess TILT Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. TILT Holdings has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

TILT Future Performance

 How is TILT Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
153.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is TILT Holdings expected to grow at an attractive rate?
  • TILT Holdings's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • TILT Holdings's earnings growth is expected to exceed the Canada market average.
  • TILT Holdings's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
CNSX:TILT Future Growth Rates Data Sources
Data Point Source Value (per year)
CNSX:TILT Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts 153.1%
CNSX:TILT Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 1 Analysts 98.2%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 110.6%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 58.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.8%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:TILT Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:TILT Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 442 29 1
2019-12-31 215 -124 1
2019-09-20
CNSX:TILT Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-06-30 77 -42 -666
2019-03-31 40 -10 -632
2018-12-31 4 -36 -546
2017-12-31 -14 -17

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • TILT Holdings's earnings are expected to grow significantly at over 20% yearly.
  • TILT Holdings's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:TILT Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from TILT Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TILT Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.08 0.08 0.08 1.00
2019-12-31 -0.36 -0.36 -0.36 1.00
2019-09-20
CNSX:TILT Past Financials Data
Date (Data in USD Millions) EPS *
2019-06-30 -2.19
2019-03-31 -2.08
2018-12-31 -18.14
2017-12-31

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if TILT Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess TILT Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
TILT Holdings has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

TILT Past Performance

  How has TILT Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare TILT Holdings's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • TILT Holdings does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.
  • Unable to compare TILT Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare TILT Holdings's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
TILT Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from TILT Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:TILT Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 76.89 -666.03 155.82
2019-03-31 40.04 -632.49 96.71
2018-12-31 3.50 -545.52 22.21
2017-12-31 -16.53 15.93

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if TILT Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if TILT Holdings has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if TILT Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess TILT Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
TILT Holdings has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

TILT Health

 How is TILT Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up TILT Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • TILT Holdings's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • TILT Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of TILT Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.7x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from TILT Holdings Company Filings, last reported 2 months ago.

CNSX:TILT Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 400.72 35.03 4.53
2019-03-31 399.16 0.72 12.11
2018-12-31 204.86 0.05 97.25
2017-12-31 -4.13 4.74 0.11
  • TILT Holdings's level of debt (8.7%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if TILT Holdings's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • TILT Holdings has less than a year of cash runway based on current free cash flow.
  • Unable to confirm if TILT Holdings has at least 1 year of cash runway based on growing free cash flows without relevant data.
X
Financial health checks
We assess TILT Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. TILT Holdings has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

TILT Dividends

 What is TILT Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from TILT Holdings dividends.
If you bought CA$2,000 of TILT Holdings shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate TILT Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate TILT Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:TILT Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.8%
Canada Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

CNSX:TILT Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2019-12-31
2019-09-20

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as TILT Holdings has not reported any payouts.
  • Unable to verify if TILT Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of TILT Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as TILT Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess TILT Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can TILT Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. TILT Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

TILT Management

 What is the CEO of TILT Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mark Scatterday
AGE 50
TENURE AS CEO 0.3 years
CEO Bio

Mr. Mark Scatterday is the Chairman of the Board at TILT Holdings Inc., since June 2019 and its Chief Executive Officer since May 10, 2019 also Director since April 2019. Mr. Scatterday is a lifelong entrepreneur and operator, having built a number of successful businesses. He was the founder of Jupiter Research, a leading provider of vaporization and inhalation devices for the cannabis industry, which is now a wholly-owned subsidiary of TILT. He served as President and Chief Executive Officer of Jupiter Research, LLC since 2015.

CEO Compensation
  • Insufficient data for Mark to compare compensation growth.
  • Insufficient data for Mark to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the TILT Holdings management team in years:

0.3
Average Tenure
45
Average Age
  • The average tenure for the TILT Holdings management team is less than 2 years, this suggests a new team.
Management Team

Mark Scatterday

TITLE
Chairman of the Board & Interim CEO
AGE
50
TENURE
0.3 yrs

Tim Conder

TITLE
Chief Operating Officer
TENURE
0.2 yrs

Joel Milton

TITLE
Senior VP of Business Development & Director
AGE
31
TENURE
0.3 yrs

Geoff Hamm

TITLE
Senior VP of Operations & Director
AGE
45
Board of Directors Tenure

Average tenure and age of the TILT Holdings board of directors in years:

0.3
Average Tenure
47.5
Average Age
  • The average tenure for the TILT Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Mark Scatterday

TITLE
Chairman of the Board & Interim CEO
AGE
50
TENURE
0.3 yrs

Joel Milton

TITLE
Senior VP of Business Development & Director
AGE
31
TENURE
0.3 yrs

Geoff Hamm

TITLE
Senior VP of Operations & Director
AGE
45
TENURE
0.8 yrs

Gary Smith

TITLE
Director
AGE
56
TENURE
0.7 yrs

Mark Cole

TITLE
Director
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess TILT Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. TILT Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

TILT News

Simply Wall St News

TILT Company Info

Description

TILT Holdings Inc., a vertically-integrated infrastructure and technology cannabis company, provides various products and services to businesses operating in the cannabis industry in the United States, Canada, and Europe. The company is organized in two business units, Software & Services, and Consumer Devices & Packaged Goods. It offers the contract manufacturing of marijuana in various form factors, vaporizer and inhalation devices, and business and consumer delivery services, as well as a suite of software products to retailers and brands. TILT Holdings Inc. serves multi-state operators, independent retailers, brands, and service providers. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.

Details
Name: TILT Holdings Inc.
TILT
Exchange: CNSX
Founded: 2017
CA$144,781,329
304,802,798
Website: http://www.tiltholdings.com
Address: TILT Holdings Inc.
1385 Cambridge Street,
Cambridge,
Massachusetts, 02138,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX TILT Common Shares Canadian National Stock Exchange CA CAD 22. Nov 2018
OTCPK TLLT.F Common Shares Pink Sheets LLC US USD 22. Nov 2018
DB 0T01 Common Shares Deutsche Boerse AG DE EUR 22. Nov 2018
Number of employees
Current staff
Staff numbers
400
TILT Holdings employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/20 01:33
End of day share price update: 2019/09/19 00:00
Last estimates confirmation: 2019/09/09
Last earnings filing: 2019/08/28
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.